BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Burgess DJ. Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment. Acta Pharm Sin B 2020;10:2110-24. [PMID: 33304781 DOI: 10.1016/j.apsb.2020.05.008] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 23.5] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Z, Zhou Z, Zhang Q, Zhou X, Yang J, Yang MR, Zhu GY, Jiang ZH, Li T, Lin Q, Bai LP. Non-classical cardenolides from Calotropis gigantea exhibit anticancer effect as HIF-1 inhibitors. Bioorg Chem 2021;109:104740. [PMID: 33626453 DOI: 10.1016/j.bioorg.2021.104740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lin Y, Li S, Xiao Z, Chen S, Yang L, Peng Q, Li H, Fu J, Yu X, Zhang L. Epigenetic inhibition assisted chemotherapeutic treatment of lung cancer based on artificial exosomes. Pharmacol Res 2021;171:105787. [PMID: 34314859 DOI: 10.1016/j.phrs.2021.105787] [Reference Citation Analysis]
3 Zheng C, Zhang W, Wang J, Zhai Y, Xiong F, Cai Y, Gong X, Zhu B, Zhu HH, Wang H, Li Y, Zhang P. Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.021] [Reference Citation Analysis]
4 Khafaga AF, Shamma RN, Abdeen A, Barakat AM, Noreldin AE, Elzoghby AO, Sallam MA. Celecoxib repurposing in cancer therapy: molecular mechanisms and nanomedicine-based delivery technologies. Nanomedicine (Lond) 2021;16:1691-712. [PMID: 34264123 DOI: 10.2217/nnm-2021-0086] [Reference Citation Analysis]
5 Bidan N, Lores S, Vanhecke A, Nicolas V, Domenichini S, López R, de la Fuente M, Mura S. Before in vivo studies: In vitro screening of sphingomyelin nanosystems using a relevant 3D multicellular pancreatic tumor spheroid model. Int J Pharm 2022;:121577. [PMID: 35167901 DOI: 10.1016/j.ijpharm.2022.121577] [Reference Citation Analysis]
6 Yadav P, Jain J, Sherje AP. Recent advances in nanocarriers-based drug delivery for cancer therapeutics: A review. Reactive and Functional Polymers 2021;165:104970. [DOI: 10.1016/j.reactfunctpolym.2021.104970] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Tang L, Xiao Q, Mei Y, He S, Zhang Z, Wang R, Wang W. Insights on functionalized carbon nanotubes for cancer theranostics. J Nanobiotechnology 2021;19:423. [PMID: 34915901 DOI: 10.1186/s12951-021-01174-y] [Reference Citation Analysis]
8 Sharma N, Bietar K, Stochaj U. Targeting nanoparticles to malignant tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022. [DOI: 10.1016/j.bbcan.2022.188703] [Reference Citation Analysis]
9 Du X, Hou Y, Huang J, Pang Y, Ruan C, Wu W, Xu C, Zhang H, Yin L, He W. Cytosolic delivery of the immunological adjuvant Poly I:C and cytotoxic drug crystals via a carrier-free strategy significantly amplifies immune response. Acta Pharm Sin B 2021;11:3272-85. [PMID: 34729315 DOI: 10.1016/j.apsb.2021.03.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Hu C, Gao H. A cleavable self-delivery nanoparticle for tumor photo-immunotherapy. Asian J Pharm Sci 2021;16:133-5. [PMID: 33763155 DOI: 10.1016/j.ajps.2021.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Peng S, Xiao F, Chen M, Gao H. Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy. Adv Sci (Weinh) 2022;9:e2103836. [PMID: 34796689 DOI: 10.1002/advs.202103836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
12 Xie X, Song T, Feng Y, Zhang H, Yang G, Wu C, You F, Liu Y, Yang H. Nanotechnology-based multifunctional vaccines for cancer immunotherapy. Chemical Engineering Journal 2022;437:135505. [DOI: 10.1016/j.cej.2022.135505] [Reference Citation Analysis]
13 Duan XC, Peng LY, Yao X, Xu MQ, Li H, Zhang SQ, Li ZY, Wang JR, Feng ZH, Wang GX, Liao A, Chen Y, Zhang X. The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death. Drug Deliv 2021;28:800-13. [PMID: 33866918 DOI: 10.1080/10717544.2021.1909180] [Reference Citation Analysis]
14 Wang X, Mohammad IS, Fan L, Zhao Z, Nurunnabi M, Sallam MA, Wu J, Chen Z, Yin L, He W. Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharm Sin B 2021;11:2585-604. [PMID: 34522599 DOI: 10.1016/j.apsb.2021.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
15 Foglizzo V, Marchiò S. Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy. Cancers (Basel) 2022;14:2473. [PMID: 35626078 DOI: 10.3390/cancers14102473] [Reference Citation Analysis]
16 Lin X, Wu J, Liu Y, Lin N, Hu J, Zhang B. Stimuli-Responsive Drug Delivery Systems for the Diagnosis and Therapy of Lung Cancer. Molecules 2022;27:948. [DOI: 10.3390/molecules27030948] [Reference Citation Analysis]
17 Wang Y, Zhou X, Wang W, Wu Y, Qian Z, Peng Q. Sodium bicarbonate, an inorganic salt and a potential active agent for cancer therapy. Chinese Chemical Letters 2021;32:3687-95. [DOI: 10.1016/j.cclet.2021.06.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ning B, Liu Y, Ouyang B, Su X, Guo H, Pang Z, Shen S. Low-temperature photothermal irradiation triggers alkyl radicals burst for potentiating cancer immunotherapy. J Colloid Interface Sci 2022;614:436-50. [PMID: 35108635 DOI: 10.1016/j.jcis.2022.01.131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Boix-Montesinos P, Soriano-Teruel PM, Armiñán A, Orzáez M, Vicent MJ. The past, present, and future of breast cancer models for nanomedicine development. Adv Drug Deliv Rev 2021;173:306-30. [PMID: 33798642 DOI: 10.1016/j.addr.2021.03.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 19.0] [Reference Citation Analysis]
20 Li Z, Gao Y, Li W, Li Y, Lv H, Zhang D, Peng J, Cheng W, Mei L, Chen H, Zeng X. Charge-reversal nanomedicines as a smart bullet for deep tumor penetration. Smart Materials in Medicine 2022. [DOI: 10.1016/j.smaim.2022.01.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
21 Xiang Y, Liu C, Chen L, Li L, Huang Y. Active Targeting Nanoparticle Self‐Assembled from Cisplatin‐Palbociclib Amphiphiles Ensures Optimal Drug Ratio for Combinatorial Chemotherapy. Adv Therap 2021;4:2000261. [DOI: 10.1002/adtp.202000261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ren H, Yong J, Yang Q, Yang Z, Liu Z, Xu Y, Wang H, Jiang X, Miao W, Li X. Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy. Acta Pharm Sin B 2021;11:3244-61. [PMID: 34729313 DOI: 10.1016/j.apsb.2021.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Yu W, Hu C, Gao H. Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages. Adv Drug Deliv Rev 2021;178:113909. [PMID: 34352354 DOI: 10.1016/j.addr.2021.113909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
24 Meng X, Zhang Z, Tong J, Sun H, Fawcett JP, Gu J. The biological fate of the polymer nanocarrier material monomethoxy poly(ethylene glycol)-block-poly(d,l-lactic acid) in rat. Acta Pharm Sin B 2021;11:1003-9. [PMID: 33996412 DOI: 10.1016/j.apsb.2021.02.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
25 Khedri M, Afsharchi F, Souderjani AH, Rezvantalab S, Didandeh M, Maleki R, Musaie K, Santos HA, Shahbazi M. Molecular scale study on the interactions of biocompatible nanoparticles with macrophage membrane and blood proteins. Nano Select. [DOI: 10.1002/nano.202200043] [Reference Citation Analysis]
26 Kutoka PT, Seidu TA, Baye V, Khamis AM, Omonova CTQ, Wang B. Current nano-strategies to target tumor microenvironment (TME) to improve anti-tumor efficiency. OpenNano 2022;7:100041. [DOI: 10.1016/j.onano.2022.100041] [Reference Citation Analysis]
27 Xie R, Ruan S, Liu J, Qin L, Yang C, Tong F, Lei T, Shevtsov M, Gao H, Qin Y. Furin-instructed aggregated gold nanoparticles for re-educating tumor associated macrophages and overcoming breast cancer chemoresistance. Biomaterials 2021;275:120891. [PMID: 34051669 DOI: 10.1016/j.biomaterials.2021.120891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Ding H, Tan P, Fu S, Tian X, Zhang H, Ma X, Gu Z, Luo K. Preparation and application of pH-responsive drug delivery systems. J Control Release 2022:S0168-3659(22)00327-3. [PMID: 35660634 DOI: 10.1016/j.jconrel.2022.05.056] [Reference Citation Analysis]
29 Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, Gu Z, Ma X, Luo K. Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency. Adv Sci (Weinh) 2022;:e2201734. [PMID: 35652198 DOI: 10.1002/advs.202201734] [Reference Citation Analysis]
30 Hu C, He X, Chen Y, Yang X, Qin L, Lei T, Zhou Y, Gong T, Huang Y, Gao H. Metformin Mediated PD‐L1 Downregulation in Combination with Photodynamic‐Immunotherapy for Treatment of Breast Cancer. Adv Funct Mater 2021;31:2007149. [DOI: 10.1002/adfm.202007149] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 33.0] [Reference Citation Analysis]
31 Loh JS, Tan LKS, Lee WL, Ming LC, How CW, Foo JB, Kifli N, Goh BH, Ong YS. Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids? Cancers (Basel) 2021;13:5346. [PMID: 34771511 DOI: 10.3390/cancers13215346] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Gao H, Pang Z, He W. Editorial of Special Issue on Tumor Microenvironment and Drug Delivery. Acta Pharm Sin B 2020;10:2016-7. [PMID: 33304776 DOI: 10.1016/j.apsb.2020.11.017] [Reference Citation Analysis]
33 Qiao Q, Liu X, Yang T, Cui K, Kong L, Yang C, Zhang Z. Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design. Acta Pharm Sin B 2021;11:3060-91. [PMID: 33977080 DOI: 10.1016/j.apsb.2021.04.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
34 Fan W, Peng H, Yu Z, Wang L, He H, Ma Y, Qi J, Lu Y, Wu W. The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers. Acta Pharm Sin B 2022;12:2479-93. [PMID: 35646531 DOI: 10.1016/j.apsb.2021.11.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Teng C, Li B, Lin C, Xing X, Huang F, Yang Y, Li Y, Azevedo HS, He W. Targeted delivery of baicalein-p53 complex to smooth muscle cells reverses pulmonary hypertension. J Control Release 2021;341:591-604. [PMID: 34896449 DOI: 10.1016/j.jconrel.2021.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
36 Flores de los Rios PA, Casañas Pimentel RG, San Martín Martínez E. Nanodrugs against cancer: biological considerations in its redesign. International Journal of Polymeric Materials and Polymeric Biomaterials. [DOI: 10.1080/00914037.2022.2097680] [Reference Citation Analysis]
37 Li J, Burgess DJ. Biomarker monitoring and long-acting insulin treatment in a stress model to facilitate personalized diabetic control. J Control Release 2021;332:21-8. [PMID: 33600878 DOI: 10.1016/j.jconrel.2021.02.013] [Reference Citation Analysis]
38 Shariatzadeh S, Moghimi N, Khalafi F, Shafiee S, Mehrabi M, Ilkhani S, Tosan F, Nakhaei P, Alizadeh A, Varma RS, Taheri M. Metallic Nanoparticles for the Modulation of Tumor Microenvironment; A New Horizon. Front Bioeng Biotechnol 2022;10:847433. [DOI: 10.3389/fbioe.2022.847433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 Wang Y, Wang J, Zhu D, Wang Y, Qing G, Zhang Y, Liu X, Liang XJ. Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies. Acta Pharm Sin B 2021;11:886-902. [PMID: 33996405 DOI: 10.1016/j.apsb.2021.03.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
40 He Q, Gao H, Tan D, Zhang H, Wang JZ. mRNA cancer vaccines: Advances, trends and challenges. Acta Pharm Sin B 2022. [PMID: 35345451 DOI: 10.1016/j.apsb.2022.03.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Gao S, Yang X, Xu J, Qiu N, Zhai G. Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment. ACS Nano 2021. [PMID: 34339170 DOI: 10.1021/acsnano.1c02103] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
42 Waglewska E, Pucek-Kaczmarek A, Bazylińska U. Self-assembled bilosomes with stimuli-responsive properties as bioinspired dual-tunable nanoplatform for pH/temperature-triggered release of hybrid cargo. Colloids Surf B Biointerfaces 2022;215:112524. [PMID: 35500532 DOI: 10.1016/j.colsurfb.2022.112524] [Reference Citation Analysis]
43 Liu Y, Sukumar UK, Kanada M, Krishnan A, Massoud TF, Paulmurugan R. Camouflaged Hybrid Cancer Cell-Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple-Negative Breast Cancer to Doxorubicin. Adv Funct Mater 2021;31:2103600. [PMID: 34899115 DOI: 10.1002/adfm.202103600] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Garofalo C, De Marco C, Cristiani CM. NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma. Front Oncol 2021;11:754541. [PMID: 34712615 DOI: 10.3389/fonc.2021.754541] [Reference Citation Analysis]